Your browser is no longer supported. Please, upgrade your browser.
Settings
BIOD Biodel Inc. daily Stock Chart
BIOD [NASD]
Biodel Inc.
Index- P/E- EPS (ttm)-0.40 Insider Own5.66% Shs Outstand64.11M Perf Week-1.29%
Market Cap26.58M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float63.92M Perf Month25.64%
Income-17.30M PEG- EPS next Q-0.04 Inst Own22.70% Short Float0.57% Perf Quarter65.84%
Sales- P/S- EPS this Y30.80% Inst Trans37.21% Short Ratio0.30 Perf Half Y9.11%
Book/sh0.57 P/B0.73 EPS next Y- ROA-48.20% Target Price3.50 Perf Year-63.95%
Cash/sh0.58 P/C0.72 EPS next 5Y- ROE-51.30% 52W Range0.22 - 1.23 Perf YTD21.94%
Dividend- P/FCF- EPS past 5Y40.90% ROI- 52W High-66.29% Beta2.00
Dividend %- Quick Ratio26.50 Sales past 5Y- Gross Margin- 52W Low88.45% ATR0.02
Employees24 Current Ratio26.50 Sales Q/Q- Oper. Margin- RSI (14)64.38 Volatility4.73% 5.38%
OptionableYes Debt/Eq0.00 EPS Q/Q74.70% Profit Margin- Rel Volume1.38 Prev Close0.42
ShortableYes LT Debt/Eq0.00 EarningsMay 05 AMC Payout- Avg Volume1.19M Price0.41
Recom3.00 SMA206.11% SMA5016.37% SMA200-10.49% Volume1,640,298 Change-0.69%
Dec-18-15Downgrade Ladenburg Thalmann Buy → Neutral
May-18-15Initiated ROTH Capital Buy $5
May-10-13Upgrade Ladenburg Thalmann Neutral → Buy $6
Apr-16-12Upgrade JMP Securities Mkt Perform → Mkt Outperform $3
May-26-11Initiated Global Hunter Securities Accumulate $5
Feb-04-11Reiterated Wedbush Outperform $7 → $5
Dec-10-10Reiterated Wedbush Outperform $10 → $7
Nov-02-10Reiterated Wedbush Outperform $17 → $10
Nov-02-10Downgrade Ladenburg Thalmann Buy → Neutral $14 → $2
Oct-19-10Initiated JMP Securities Mkt Perform
Mar-25-09Reiterated Wedbush Morgan Buy $10 → $16
Mar-25-09Reiterated Ladenburg Thalmann Buy $9.50 → $14
Dec-11-08Reiterated Ladenburg Thalmann Buy $11 → $9.50
Nov-20-08Reiterated Cantor Fitzgerald Buy $33 → $15
Sep-19-08Downgrade Argus Buy → Sell
Sep-11-08Initiated Oppenheimer Perform
Sep-08-08Reiterated Ladenburg Thalmann Buy $23 → $11
May-16-08Initiated Cantor Fitzgerald Buy $33
May-02-08Initiated Pacific Growth Equities Buy
Feb-27-08Initiated JP Morgan Overweight
Apr-01-16 05:02PM  BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Mar-24-16 09:15AM  BIODEL INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf +6.45%
Mar-02-16 05:49PM  BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers
Feb-19-16 01:04PM  BIODEL INC Financials
Feb-16-16 08:01AM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:05AM  Biodel Reports First Quarter Fiscal Year 2016 Financial Results Marketwired
Jan-29-16 08:57AM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:00AM  Biodel Announces Restructuring Update Marketwired
Jan-27-16 04:33PM  BIODEL INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities -7.69%
Jan-15-16 06:37AM  3 Biotech Stocks Under $10 to Trade for Big Gains at TheStreet +7.69%
Dec-28-15 08:25AM  Auris Medical Holding (EARS) Looks Good: Stock Up 23.8%
Dec-22-15 04:38PM  BIODEL INC Files SEC form 10-K, Annual Report
Dec-18-15 12:56PM  Biodel downgraded by Ladenburg Thalmann +34.78%
10:47AM  4 Stocks Under $10 Showing Great Upside Today Accesswire
Dec-17-15 04:58PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition -8.00%
04:14PM  Biodel Reports Fourth Quarter and Fiscal Year 2015 Financial Results Marketwired
07:07AM  Q4 2015 Biodel Inc Earnings Release - 4:00 pm ET
Dec-14-15 07:00AM  Biodel to Report Fourth Quarter and Fiscal Year 2015 Financial Results on December 17, 2015 Marketwired
Dec-07-15 04:58PM  Novartis (NVS) Unveils Positive Data on Leukemia Candidates -9.38%
Dec-03-15 04:55PM  Immunomedics, FDA Finalize Oncology Drug Study Design
Nov-27-15 09:57AM  What Do Hedge Funds Think of EnteroMedics Inc (ETRM)? at Insider Monkey +5.56%
Nov-24-15 05:11PM  Do Hedge Funds Love AEterna Zentaris Inc. (USA) (AEZS)? at Insider Monkey
10:36AM  AEterna Zentaris Inc. (USA) (AEZS) Making Another Monster Move Today at Insider Monkey
Nov-03-15 04:34PM  BIODEL INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities
04:30PM  Biodel Announces Clinical and Corporate Updates Marketwired
Oct-19-15 04:30PM  Biodel Announces Data Presentations at the Diabetes Technology Society Conference Marketwired
09:30AM  New Strong Buy Stocks for October 19th
Oct-13-15 06:10AM  BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers
Oct-12-15 07:00AM  Biodel Announces Removal of Partial Clinical Hold for BIOD-531 and Plans for Potential Expansion of Target Patient Population Marketwired
Sep-25-15 04:31PM  BIODEL INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf
Sep-24-15 02:45PM  These 5 Healthcare Penny Stocks Are Poised To Jump at Insider Monkey
Sep-22-15 07:00AM  Biodel to Present at the Ladenburg Thalmann 2015 Healthcare Conference Marketwired -5.71%
Sep-15-15 05:08PM  BIODEL INC Files SEC form 8-K, Other Events
01:58PM  4 Stocks Under $10 Making Big Moves Higher at TheStreet
Sep-14-15 06:55PM  Biodel Announces Data Presentation at the 51st Annual Meeting of the EASD Marketwired
Sep-01-15 02:57PM  3 Breakout Biotech Stocks Trading for Under $10 at TheStreet +7.46%
Aug-16-15 08:12PM  10-Q for Biodel, Inc. at Company Spotlight
Aug-14-15 03:27PM  BIODEL INC Files SEC form 10-Q, Quarterly Report -23.16%
12:49PM  Edited Transcript of BIOD earnings conference call or presentation 13-Aug-15 9:00pm GMT
Aug-13-15 05:17PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:00PM  Biodel Reports Third Quarter Fiscal Year 2015 Financial Results Marketwired
07:07AM  Q3 2015 Biodel Inc Earnings Release - 4:00 pm ET
Aug-06-15 08:00AM  Biodel to Report Third Quarter Fiscal Year 2015 Financial Results on August 13, 2015 Marketwired
Jul-09-15 12:40PM  Galmed Inks Deal to Develop Non-Invasive Diagnostic Tool - Analyst Blog
Jun-29-15 10:04PM  Edited Transcript of BIOD presentation 24-Jun-15 6:00pm GMT
Jun-18-15 04:30PM  Biodel to Present at Two Upcoming Investor Conferences Marketwired
11:50AM  Radius Health Up on Positive Data on Fracture Candidate - Analyst Blog
Jun-17-15 12:40PM  Impax's Zomig Nasal Spray Gets FDA Nod for Pediatrics - Analyst Blog
Jun-08-15 04:31PM  BIODEL INC Files SEC form 8-K/A, Change in Directors or Principal Officers
Jun-03-15 08:09PM  10-Q/A for Biodel, Inc. at Company Spotlight
Jun-01-15 04:35PM  BIODEL INC Files SEC form 10-Q/A, Quarterly Report
May-28-15 04:00PM  Biodel to Present Data on Concentrated Ultra-Rapid-Acting/Basal Insulin and Glucagon at the 75th American Diabetes Association Scientific Sessions Marketwired
May-21-15 04:02PM  BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
07:00AM  Biodel Announces Phase 2b Clinical Trial Initiation of BIOD-531, the Company's Concentrated, Ultra-Rapid-Acting, Prandial/Basal Combination Insulin Candidate Marketwired
May-18-15 07:00AM  Biodel Appoints Ms. Arlene M. Morris to Its Board of Directors Marketwired
May-09-15 08:09PM  10-Q for Biodel, Inc. at Company Spotlight
May-07-15 05:30PM  BIODEL INC Files SEC form 10-Q, Quarterly Report
May-06-15 04:46PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:00PM  Biodel Reports Second Quarter Fiscal Year 2015 Financial Results Marketwired
07:07AM  Q2 2015 Biodel Inc Earnings Release - 4:00 pm ET
May-01-15 09:48AM  Biodel to Report Second Quarter Fiscal Year 2015 Financial Results on May 6, 2015 Marketwired
01:02AM  Biodel's Glucagon Emergency Management (GEM) Auto-Reconstitution Device Demonstrates Superior Usability Compared to Marketed Glucagon Kits in Human Factors Study at noodls
01:02AM  Biodel Announces Pricing of Public Offering of Common Stock at noodls
Apr-20-15 10:03AM  BIODEL INC Files SEC form 8-K, Other Events
Apr-16-15 06:03PM  Nasdaq stocks posting largest volume increases
Apr-15-15 10:42AM  BIODEL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agree +10.68%
08:00AM  Biodel Announces Pricing of Public Offering of Common Stock Marketwired
Apr-06-15 08:17AM  BIODEL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Biodel's Glucagon Emergency Management (GEM) Auto-Reconstitution Device Demonstrates Superior Usability Compared to Marketed Glucagon Kits in Human Factors Study Marketwired
Apr-01-15 12:15AM  Biodel's Glucagon Formulation for Use in a Proprietary Auto-Reconstitution Device for the Treatment of Severe Hypoglycemia Meets Primary Efficacy Endpoint in Phase 1 Clinical Trial at noodls
12:15AM  Biodel to Present at the 27th Annual ROTH Conference at noodls
Mar-18-15 01:30PM  BIODEL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
Mar-16-15 08:41AM  BIODEL INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
07:00AM  Biodel's Glucagon Formulation for Use in a Proprietary Auto-Reconstitution Device for the Treatment of Severe Hypoglycemia Meets Primary Efficacy Endpoint in Phase 1 Clinical Trial Marketwired
Mar-04-15 08:00AM  Biodel to Present at the 27th Annual ROTH Conference Marketwired
Mar-01-15 01:56AM  Biodel Reports First Quarter Fiscal Year 2015 Financial Results at noodls
Feb-14-15 07:07PM  10-Q for Biodel, Inc. at Company Spotlight
Feb-12-15 05:01PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:00PM  BIODEL INC Files SEC form 10-Q, Quarterly Report
04:06PM  Pacira Resolves Promotion Issues Related to Exparel - Analyst Blog
04:00PM  Biodel Reports First Quarter Fiscal Year 2015 Financial Results Marketwired
07:07AM  Q1 2015 Biodel Inc Earnings Release - 4:00 pm ET CCBN
Feb-09-15 05:58PM  UCB's Neupro Positive in Parkinson's Disease Study in China - Analyst Blog Zacks
Feb-06-15 09:32AM  McKesson Beats on Earnings & Revenues in Q3, Ups View - Analyst Blog Zacks
09:00AM  On MannKind, Diabetics Have One Up On Wall Street at Forbes
Feb-05-15 06:27PM  Roche Reports Positive Data on Leukemia Drug Gazyva - Analyst Blog Zacks
03:31PM  BioSpecifics Announces Label Expansion for Xiaflex in EU - Analyst Blog Zacks
08:00AM  Biodel to Report First Quarter Fiscal Year 2015 Financial Results on February 12, 2015 Marketwired
Feb-04-15 06:46PM  Merck KGaA, Precision Biologics to Develop Cancer Antibody - Analyst Blog Zacks
06:07PM  Novartis' Alcon Receives FDA Approval for Pazeo Solution - Analyst Blog Zacks
09:21AM  Salix Pharmaceuticals (SLXP) in Focus: Stock Jumps 5.1% - Tale of the Tape Zacks
Feb-03-15 03:45PM  Will McKesson (MCK) Disappoint Q3 Earnings Estimates? - Analyst Blog Zacks
11:03AM  Mallinckrodt Beats on Q1 Earnings, Sales Miss Estimates - Analyst Blog Zacks
Feb-02-15 05:50PM  Will Mallinckrodt (MNK) Disappoint Q1 Earnings Estimates? - Analyst Blog Zacks
03:45PM  Shire's Vyvanse Label Expanded for Binge-Eating Disorder - Analyst Blog Zacks
03:20PM  Will Allergan (AGN) Disappoint on Earnings This Quarter? - Analyst Blog Zacks
Jan-30-15 05:55PM  Pharmacyclics Up on Imbruvica Label Expansion in the U.S. - Analyst Blog Zacks
Jan-29-15 05:30PM  Galmed, Perrigo Tie Up for Mass Production of Aramchol API - Analyst Blog Zacks
04:30PM  Will Generics Continue to Hit Eli Lilly's (LLY) Q4 Earnings? - Analyst Blog Zacks
Jan-28-15 06:30PM  Will Abbott Labs (ABT) Disappoint on Earnings This Quarter? - Analyst Blog Zacks
Biodel Inc., a specialty biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes in the United States. Its lead product candidate is a glucagon emergency management (GEM) device that is intended to treat diabetes patients experiencing severe hypoglycemia, or very low concentrations of blood glucose. The company completed a Phase 1 clinical trial to assess the pharmacokinetic and pharmacodynamic profiles of BIOD-961, the reconstituted glucagon formulation intended for use in the GEM device. It also develops ultra-rapid-acting proprietary insulin formulations, such as BIOD-531, a concentrated ultra-rapid-acting insulin formulation. In addition, the company develops pre-clinical analog-based ultra-rapid-acting insulin formulations using insulin lispro, the active pharmaceutical ingredient in Humalog, as well as insulin aspart, the active pharmaceutical ingredient in NovoLog. Biodel Inc. was founded in 2003 and is headquartered in Danbury, Connecticut.